Insider Trading
ADVM Stock Insider Trading Activity
Corporate insiders are required to disclose purchases or sales of their own stock within two business days of when they occur. Using these disclosures, we collect data on ADVM stock insider trading activity, which can give hints on whether executives are bullish or bearish on their own company.
Recent insider purchases and sales - ADVM
| Name / Title | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
|
Scopa James Paul
|
Purchase | 100000 | Feb 07, 2024 | Feb. 9, 2024, 6:51 p.m. |
|
Lupher, Jr. Mark L.
|
Purchase | 130000 | Feb 07, 2024 | Feb. 9, 2024, 6:50 p.m. |
|
Seyedkazemi Setareh
Chief Development Officer
|
Sale | 6071 | Sep 15, 2023 | Sept. 18, 2023, 6:54 p.m. |
|
Seyedkazemi Setareh
Chief Development Officer
|
Sale | 130 | Sep 15, 2023 | Sept. 18, 2023, 6:54 p.m. |
|
Rubinstein Linda M
Chief Financial Officer
|
Purchase | 100000 | Jun 07, 2023 | June 9, 2023, 4:26 p.m. |
|
Riley Brigit
Chief Scientific Officer
|
Sale | 7299 | Mar 15, 2023 | March 17, 2023, 6:02 p.m. |
|
Soparkar Peter
Chief Operating Officer
|
Sale | 13360 | Mar 15, 2023 | March 17, 2023, 6:02 p.m. |
|
Fischer Laurent
CEO, President and Director
|
Sale | 41239 | Mar 15, 2023 | March 17, 2023, 6:01 p.m. |
|
Beckman Richard
Chief Medical Officer
|
Sale | 4272 | Sep 19, 2022 | Sept. 21, 2022, 8:01 p.m. |
|
Seyedkazemi Setareh
Chief Development Officer
|
Sale | 6058 | Sep 19, 2022 | Sept. 21, 2022, 8 p.m. |
|
Soparkar Peter
See Remarks section
|
Sale | 13305 | Sep 19, 2022 | Sept. 21, 2022, 7:59 p.m. |
|
Riley Brigit
Chief Scientific Officer
|
Sale | 7266 | Sep 19, 2022 | Sept. 21, 2022, 7:58 p.m. |
|
Fischer Laurent
CEO, President and Director
|
Sale | 41082 | Sep 19, 2022 | Sept. 21, 2022, 7:57 p.m. |
|
Seyedkazemi Setareh
Chief Development Officer
|
Purchase | 20000 | May 23, 2022 | May 24, 2022, 4:47 p.m. |
|
Beckman Richard
Chief Medical Officer
|
Purchase | 10000 | May 17, 2022 | May 19, 2022, 7:43 p.m. |
|
Svoronos Dawn
|
Purchase | 30000 | May 16, 2022 | May 18, 2022, 4:43 p.m. |
|
D'Souza Rupert
Chief Financial Officer
|
Purchase | 10000 | May 13, 2022 | May 17, 2022, 6:28 p.m. |
|
D'Souza Rupert
Chief Financial Officer
|
Purchase | 10000 | May 17, 2022 | May 17, 2022, 6:28 p.m. |
|
Fischer Laurent
CEO, President and Director
|
Purchase | 25000 | Apr 20, 2022 | April 22, 2022, 5 p.m. |
|
Soparkar Peter
See Remarks section
|
Purchase | 175 | Apr 19, 2022 | April 20, 2022, 4:35 p.m. |
|
Soparkar Peter
See Remarks section
|
Purchase | 21750 | Apr 19, 2022 | April 20, 2022, 4:35 p.m. |
|
Fischer Laurent
CEO, President and Director
|
Purchase | 14323 | Dec 09, 2021 | Dec. 10, 2021, 6:26 p.m. |
|
Fischer Laurent
CEO, President and Director
|
Purchase | 10677 | Dec 08, 2021 | Dec. 10, 2021, 6:26 p.m. |
|
Soparkar Peter
See Remarks section
|
Purchase | 25000 | Dec 08, 2021 | Dec. 10, 2021, 6:26 p.m. |
|
Scopa James Paul
|
Sale | 50000 | Nov 15, 2021 | Nov. 17, 2021, 5:38 p.m. |
|
Clark Julie
Chief Medical Officer
|
Sale | 4766 | Sep 30, 2021 | Oct. 3, 2021, 8 p.m. |